The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review
Wenfang Zhu et al · Elsevier · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, W. Z. E. (2026). The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review. https://doi.org/10.1016/j.ahjo.2026.100768
MLA
al, Wenfang Zhu et. "The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review." 2026. https://doi.org/10.1016/j.ahjo.2026.100768.
Chicago
al, Wenfang Zhu et. 2026. "The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review.". https://doi.org/10.1016/j.ahjo.2026.100768.
Harvard
al, W. Z. E. 2026, The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review, Elsevier, available at: https://doi.org/10.1016/j.ahjo.2026.100768 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review
- Autor / colaboradores
- Wenfang Zhu et al
- Editorial
- Elsevier
- Año de publicación
- 2026
- ISSN
- 2666-6022
- ISSN
- 2666-6022
- Idioma
- eng